<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38279014</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1076</ISSN><JournalIssue CitedMedium="Internet"><Volume>183</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of pediatrics</Title><ISOAbbreviation>Eur J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Long COVID in pediatrics-epidemiology, diagnosis, and management.</ArticleTitle><Pagination><StartPage>1543</StartPage><EndPage>1553</EndPage><MedlinePgn>1543-1553</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00431-023-05360-y</ELocationID><Abstract><AbstractText>This review summarizes current knowledge on post-acute sequelae of COVID-19 (PASC) and post-COVID-19 condition (PCC) in children and adolescents. A literature review was performed to synthesize information from clinical studies, expert opinions, and guidelines. PASC also termed Long COVID&#xa0;-&#xa0;at any age comprise a plethora of unspecific symptoms present later than 4&#xa0;weeks after confirmed or probable infection with severe respiratory syndrome corona virus type 2 (SARS-CoV-2), without another medical explanation. PCC in children and adolescents was defined by the WHO as PASC occurring within 3&#xa0;months of acute coronavirus disease 2019 (COVID-19), lasting at least 2&#xa0;months, and limiting daily activities. Pediatric PASC mostly manifest after mild courses of COVID-19 and in the majority of cases remit after few months. However, symptoms can last for more than 1&#xa0;year and may result in significant disability. Frequent symptoms include fatigue, exertion intolerance, and anxiety. Some patients present with postural tachycardia syndrome (PoTS), and a small number of cases fulfill the clinical criteria of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). To date, no diagnostic marker has been established, and differential diagnostics remains challenging. Therapeutic approaches include appropriate self-management as well as the palliation of symptoms by non-pharmaceutical and pharmaceutical strategies. &#xa0; &#xa0;Conclusion: PASC in pediatrics present with heterogenous severity and duration. A stepped, interdisciplinary, and individualized approach is essential for appropriate clinical management. Current health care structures have to be adapted, and research was extended to meet the medical and psychosocial needs of young people with PASC or similar conditions. What is Known: &#x2022; Post-acute sequelae of coronavirus 2019 (COVID-19) (PASC)&#xa0;-&#xa0;also termed Long COVID&#xa0;-&#xa0;in children and adolescents can lead to activity limitation and reduced quality of life. &#x2022; PASC belongs to a large group of similar post-acute infection syndromes (PAIS).&#xa0;Specific biomarkers and causal treatment options are not yet available. What is New: &#x2022; In February 2023, a case definition for post COVID-19 condition (PCC) in children and adolescents was provided by the World Health Organization (WHO), indicating PASC with duration of at least 2&#xa0;months and limitation of daily activities.&#xa0;PCC can present as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). &#x2022; Interdisciplinary collaborations are necessary and have been established worldwide to offer harmonized, multimodal approaches to diagnosis and management of PASC/PCC in children and adolescents.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toepfner</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9693-4419</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany. Nicole.Toepfner@ukdd.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinkmann</LastName><ForeName>Folke</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Pediatric Pulmonology and Allergology, University Children's Hospital, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Luebeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Augustin</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MRI Chronic Fatigue Center for Young People, Pediatrics, Children's Hospital, Technical University Munich and Munich Municipal Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stojanov</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MRI Chronic Fatigue Center for Young People, Child and Adolescent Psychosomatics, Children's Hospital, Technical University Munich and Munich Municipal Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrends</LastName><ForeName>Uta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>MRI Chronic Fatigue Center for Young People, Pediatrics, Children's Hospital, Technical University Munich and Munich Municipal Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Pediatr</MedlineTA><NlmUniqueID>7603873</NlmUniqueID><ISSNLinking>0340-6199</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome (PCS)</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 condition (PCC)</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19 (PASC)</Keyword><Keyword MajorTopicYN="N">Post-exertional malaise (PEM)</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38279014</ArticleId><ArticleId IdType="pmc">PMC11001657</ArticleId><ArticleId IdType="doi">10.1007/s00431-023-05360-y</ArticleId><ArticleId IdType="pii">10.1007/s00431-023-05360-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alwan NA. A negative COVID-19 test does not mean recovery. Nature. 2020;584:170&#x2013;170. doi: 10.1038/d41586-020-02335-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02335-z</ArticleId><ArticleId IdType="pubmed">32782377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4:1&#x2013;17. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;pfner N, Alberer M, Ankermann T, et al. Einheitliche Basisversorgung von Kindern und Jugendlichen mit Long COVID. Monatsschrift Kinderheilkunde. 2022;170:539&#x2013;547. doi: 10.1007/s00112-021-01408-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00112-021-01408-1</ArticleId><ArticleId IdType="pmc">PMC9131710</ArticleId><ArticleId IdType="pubmed">35637934</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, et al. S1-Leitlinie long-/post-COVID. Pneumologie. 2022;76:855&#x2013;907. doi: 10.1055/a-1946-3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1946-3230</ArticleId><ArticleId IdType="pubmed">36479679</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) (2021) New ICD-10-CM code for post-COVID conditions, following the 2019 novel coronavirus (COVID-19). https://www.cdc.gov/nchs/data/icd/announcement-new-icd-code-for-post-covid-condition-april-2022-final.pdf</Citation></Reference><Reference><Citation>Bundesinstitut f&#xfc;r Arzneimittel und Medizinprodukte (DIMDI) (2021) ICD-10-GM Version 2021. Kapitel XXII Schl&#xfc;sselnummern f&#xfc;r besondere Zwecke (U00-U99). https://www.dimdi.de/static/de/klassifikationen/icd/icd-10-gm/kode-suche/htmlgm2021/block-u00-u49.htm</Citation></Reference><Reference><Citation>Pellegrino R, Chiappini E, Licari A, et al. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181:3995&#x2013;4009. doi: 10.1007/s00431-022-04600-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04600-x</ArticleId><ArticleId IdType="pmc">PMC9476461</ArticleId><ArticleId IdType="pubmed">36107254</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. The challenge of studying long COVID: an updated review. Pediatric Infectious Disease Journal. 2022;41:424&#x2013;426. doi: 10.1097/INF.0000000000003502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003502</ArticleId><ArticleId IdType="pmc">PMC8997013</ArticleId><ArticleId IdType="pubmed">35213866</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, Berlit P, Berner R, B&#xf6;ing S, Brinkmann F, Frank U, Franke C, Gl&#xf6;ckl R, Gogoll C (2022)&#xa0;S1-Leitlinie long/post-COVID - living guideline. AWMF online: Das Portal der wissenschaftichen Medizin. https://register.awmf.org/de/leitlinien/detail/020-027</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19, NICE guideline [NG188]. Last updated: 11 November 2021. https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Allin B, Nugawela MD, et al. Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) (2023) A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1</Citation></Reference><Reference><Citation>Hallek M, Adorjan K, Behrends U, et al. Post-COVID syndrome. Dtsch Arztebl Int. 2023 doi: 10.3238/arztebl.m2022.0409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0409</ArticleId><ArticleId IdType="pmc">PMC10060997</ArticleId><ArticleId IdType="pubmed">36633452</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, Ladhani SN. Long COVID in children and adolescents. Curr Opin Infect Dis. 2022;35:461&#x2013;467. doi: 10.1097/QCO.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000854</ArticleId><ArticleId IdType="pmc">PMC9553244</ArticleId><ArticleId IdType="pubmed">36098262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha EK, Kim JH, Han MY. Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies. Clinical and Experimental Pediatrics. 2023 doi: 10.3345/cep.2023.00472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/cep.2023.00472</ArticleId><ArticleId IdType="pmc">PMC10626026</ArticleId><ArticleId IdType="pubmed">37350170</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M, Tesch F, Batram M, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19:e1004122. doi: 10.1371/journal.pmed.1004122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, Authier FJ, Scheibenbogen C, et al. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina. 2021;57:510. doi: 10.3390/medicina57050510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050510</ArticleId><ArticleId IdType="pmc">PMC8161074</ArticleId><ArticleId IdType="pubmed">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Underhill RA, Friedman KJ et al (2017) Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: a primer. Front Pedia 5.&#xa0;10.3389/fped.2017.00121</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5474682</ArticleId><ArticleId IdType="pubmed">28674681</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Myalgic encephalomyelitis/chronic fatigue syndrome. Symptoms and diagnosis of ME/CFS. https://www.cdc.gov/me-cfs/symptoms-diagnosis/. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>Bonilla H, Quach TC, Tiwari A et al (2023) Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol 14. 10.3389/fneur.2023.1090747</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Di GL, De RC, et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo JA, Mart&#xed;nez-L&#xf3;pez JP, Carrillo-Lamp&#xf3;n SA, et al. Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci. 2021;11:760. doi: 10.3390/brainsci11060760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060760</ArticleId><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Hartle M, Sullivan K, et al. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Work. 2023;74:1179&#x2013;1186. doi: 10.3233/WOR-220581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r ME/CSF e. V. (2023) Post-exertional malaise. https://www.mecfs.de/was-ist-me-cfs/pem/. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, et al. Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13:6009. doi: 10.1038/s41467-022-33784-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33784-x</ArticleId><ArticleId IdType="pmc">PMC9554845</ArticleId><ArticleId IdType="pubmed">36224219</ArticleId></ArticleIdList></Reference><Reference><Citation>Peo LC, Wiehler K, Paulick J, Gerrer K, Leone A, Viereck A, Haegele M, Stojanov S, Warlitz C, Augustin S, Alberer M, Hattesohl DBR, Froehlich L, Scheibenbogen C, Pricoco RBU. Pediatric and adult patients with ME/CFS following COVID-19: a structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ). In: https://www.medrxiv.org/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10951047</ArticleId><ArticleId IdType="pubmed">38095713</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe K. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in adolescents: practical guidance and management challenges. Adolesc Health Med Ther. 2023;14:13&#x2013;26. doi: 10.2147/AHMT.S317314.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/AHMT.S317314</ArticleId><ArticleId IdType="pmc">PMC9827635</ArticleId><ArticleId IdType="pubmed">36632532</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister BA. Post-infectious disease syndrome. Postgrad Med J. 1988;64:559&#x2013;567. doi: 10.1136/pgmj.64.753.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.64.753.559</ArticleId><ArticleId IdType="pmc">PMC2428896</ArticleId><ArticleId IdType="pubmed">3074289</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Author Correction: Unexplained post-acute infection syndromes. Nat Med. 2022;28:1723&#x2013;1723. doi: 10.1038/s41591-022-01952-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01952-7</ArticleId><ArticleId IdType="pubmed">35859204</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz BZ, Collin SM, Murphy G, et al. The international collaborative on fatigue following infection (COFFI). Fatigue: Biomedicine. Health &amp; Behavior. 2018;6:106&#x2013;121. doi: 10.1080/21641846.2018.1426086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2018.1426086</ArticleId><ArticleId IdType="pmc">PMC6333416</ArticleId><ArticleId IdType="pubmed">30666281</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz BZ, Shiraishi Y, Mears CJ, et al. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009;124:189&#x2013;193. doi: 10.1542/peds.2008-1879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-1879</ArticleId><ArticleId IdType="pmc">PMC2756827</ArticleId><ArticleId IdType="pubmed">19564299</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe KS (2019) Long term follow up of young people with chronic fatigue syndrome attending a pediatric outpatient service. Front Pedia 7.&#xa0;10.3389/fped.2019.00021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6393360</ArticleId><ArticleId IdType="pubmed">30847333</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchhorn R. Dysautonomia in children with post-acute sequelae of coronavirus 2019 disease and/or vaccination. Vaccines. 2022;10:1686. doi: 10.3390/vaccines10101686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101686</ArticleId><ArticleId IdType="pmc">PMC9607162</ArticleId><ArticleId IdType="pubmed">36298551</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholkmann F, May C-A. COVID-19, post-acute COVID-19 syndrome (PACS, &#x201c;long COVID&#x201d;) and post-COVID-19 vaccination syndrome (PCVS, &#x201c;post-COVIDvac-syndrome&#x201d;): similarities and differences. Pathology - Research and Practice. 2023;246:154497. doi: 10.1016/j.prp.2023.154497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2023.154497</ArticleId><ArticleId IdType="pmc">PMC10154064</ArticleId><ArticleId IdType="pubmed">37192595</ArticleId></ArticleIdList></Reference><Reference><Citation>Engels G, Hecker K, Forster J, et al. High seroprevalence of SARS-CoV-2 in preschool children in July 2022. Dtsch Arztebl Int. 2022 doi: 10.3238/arztebl.m2022.0345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0345</ArticleId><ArticleId IdType="pmc">PMC9884839</ArticleId><ArticleId IdType="pubmed">36700368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott R, Achenbach P, Ewald DA, et al. SARS-CoV-2 seroprevalence in preschool and school-age children. Dtsch Arztebl Int. 2022 doi: 10.3238/arztebl.m2022.0355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0355</ArticleId><ArticleId IdType="pmc">PMC9884841</ArticleId><ArticleId IdType="pubmed">36345616</ArticleId></ArticleIdList></Reference><Reference><Citation>Pricoco R, Meidel P, Hofberger T, Zietemann H, Mueller Y, Wiehler K, Michel K, Paulick J, Leone A, Haegele M, Mayer-Huber S. One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus. Posted 27/07/23 on MedRxiv: 10.1101/2023.07.24.23293082v1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10830704</ArticleId><ArticleId IdType="pubmed">38304441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA et al (2022) Long COVID through a public Health lens: an umbrella review. Public Health Rev 43. 10.3389/phrs.2022.1604501</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84:158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R, Martino L, Buonsenso D. Diagnosis and management of post-COVID (Long COVID) in children: a moving target. Curr Opin Pediatr. 2023;35:184&#x2013;192. doi: 10.1097/MOP.0000000000001221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000001221</ArticleId><ArticleId IdType="pmc">PMC9994801</ArticleId><ArticleId IdType="pubmed">36660968</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas S, Jagannathan P, Henrich TJ et al (2023) Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). eLife 12. 10.7554/eLife.86014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219649</ArticleId><ArticleId IdType="pubmed">37233729</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Rodr&#xed;guez Y, Acosta-Ampudia Y, et al. Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med. 2022;20:129. doi: 10.1186/s12967-022-03328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammi V, Nakanishi T, Jones SE, Andrews SJ, Karjalainen J, Cortes B, O'Brien HE, Fulton-Howard BE, Haapaniemi HH, Schmidt A, Mitchell RE et al. Genome-wide association study of long COVID. Posted 01/07/23 on medRxiv: 10.1101/2023.06.29.23292056</Citation></Reference><Reference><Citation>Szewczykowski C, Mardin C, Lucio M, et al. Long COVID: association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation. Int J Mol Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Morello R, Mariani F, et al. Risk of long Covid in children infected with Omicron or &lt;scp&gt;pre-Omicron SARS-CoV&lt;/scp&gt; -2 variants. Acta Paediatr. 2023;112:1284&#x2013;1286. doi: 10.1111/apa.16764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16764</ArticleId><ArticleId IdType="pubmed">36938946</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, et al. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. The Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB et al (2022) Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ e069676.&#xa0;10.1136/bmj-2021-069676</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Greenhalgh T, Milne R, Delaney B (2022) Are vaccines a potential treatment for long covid? BMJ o988. 10.1136/bmj.o988</Citation><ArticleIdList><ArticleId IdType="pubmed">35584848</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, et al. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar J, Havdal LB, Drevvatne M, et al. Prevalence and characteristics associated with post&#x2013;COVID-19 condition among nonhospitalized adolescents and young adults. JAMA Netw Open. 2023;6:e235763. doi: 10.1001/jamanetworkopen.2023.5763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5763</ArticleId><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21:1373&#x2013;1382. doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugawela MD, Stephenson T, Shafran R, et al. Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test. BMC Med. 2022;20:465. doi: 10.1186/s12916-022-02664-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02664-y</ArticleId><ArticleId IdType="pmc">PMC9708506</ArticleId><ArticleId IdType="pubmed">36447237</ArticleId></ArticleIdList></Reference><Reference><Citation>U. S. National Library of Medidine ClinicalTrials.gov Genetic risk factors for multi-system inflammatory syndrome in children and pediatric post COVID condition (GRIP). ClinicalTrials.gov Identifier: NCT05722717. https://classic.clinicaltrials.gov/ct2/show/NCT05722717. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>Goretzki SC, Brasseler M, Dogan B, et al. High prevalence of alternative diagnoses in children and adolescents with suspected long COVID&#x2014;a single center cohort study. Viruses. 2023;15:579. doi: 10.3390/v15020579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020579</ArticleId><ArticleId IdType="pmc">PMC9961131</ArticleId><ArticleId IdType="pubmed">36851793</ArticleId></ArticleIdList></Reference><Reference><Citation>Racine N, McArthur BA, Cooke JE, et al. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19. JAMA Pediatr. 2021;175:1142. doi: 10.1001/jamapediatrics.2021.2482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2482</ArticleId><ArticleId IdType="pmc">PMC8353576</ArticleId><ArticleId IdType="pubmed">34369987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens-Sieberer U, Devine J, Napp A-K et al (2023) Three years into the pandemic: results of the longitudinal German COPSY study on youth mental health and health-related quality of life. Front Public Health 11. 10.3389/fpubh.2023.1129073</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10307958</ArticleId><ArticleId IdType="pubmed">37397777</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J, Wekenborg MK, Reichert J, et al. Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic. Sci Rep. 2022;12:2246. doi: 10.1038/s41598-022-06166-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06166-y</ArticleId><ArticleId IdType="pmc">PMC8831534</ArticleId><ArticleId IdType="pubmed">35145161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, Dam Nielsen S, Nygaard U, et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. The Lancet Child &amp; Adolescent Health. 2022;6:240&#x2013;248. doi: 10.1016/S2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Nugawela MD, et al. Long COVID&#x2014;six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: a national matched cohort study (The CLoCk) study. PLoS ONE. 2023;18:e0277704. doi: 10.1371/journal.pone.0277704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0277704</ArticleId><ArticleId IdType="pmc">PMC9987792</ArticleId><ArticleId IdType="pubmed">36877677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorman V, Rao S, Jhaveri R et al (2023) Understanding pediatric long COVID using a tree-based scan statistic approach: an EHR-based cohort study from the RECOVER Program. JAMIA Open 6. 10.1093/jamiaopen/ooad016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10013630</ArticleId><ArticleId IdType="pubmed">36926600</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcaterra V, Tagi VM, De Santis R, et al. Endocrinological involvement in children and adolescents affected by COVID-19: a narrative review. J Clin Med. 2023;12:5248. doi: 10.3390/jcm12165248.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12165248</ArticleId><ArticleId IdType="pmc">PMC10455095</ArticleId><ArticleId IdType="pubmed">37629291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyatt KH, Jacobson LB, Schneider VS. Comparison of 70 degrees tilt, LBNP, and passive standing as measrues of orthostatic tolerance. Aviat Space Environ Med. 1975;46:801&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">1156287</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone LA, Morrow A, Chen Y, et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of postacute sequelae of SARS-CoV-2 infection (PASC) in children and adolescents. PM&amp;R. 2022;14:1241&#x2013;1269. doi: 10.1002/pmrj.12890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12890</ArticleId><ArticleId IdType="pmc">PMC9538628</ArticleId><ArticleId IdType="pubmed">36169159</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Di Giuda D, Sigfrid L, et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. The Lancet Child &amp; Adolescent Health. 2021;5:677&#x2013;680. doi: 10.1016/S2352-4642(21)00196-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00196-6</ArticleId><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss R, Tan L, Schmidt S et al (2023) Pulmonary dysfunction after pediatric COVID-19. Radiology 306.&#xa0;10.1148/radiol.221250</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513839</ArticleId><ArticleId IdType="pubmed">36125379</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason L. A brief questionnaire to assess post-exertional malaise. Diagnostics. 2018;8:66. doi: 10.3390/diagnostics8030066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics8030066</ArticleId><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Stussman B, Calco B, Norato G, Gavin A, Chigurupati S, Nath AWB. A mixed methods system for the assessment of post exertional malaise in encephalomyelitis/chronic fatigue syndrome. Posted 26/04/23 on medRxiv: 10.1101/2023.04.24.23288821</Citation></Reference><Reference><Citation>T&#xf6;pfner N, Brinkmann F. Long-/post-COVID-19 bei Kindern und Jugendlichen. Monatsschrift Kinderheilkunde. 2023;171:601&#x2013;607. doi: 10.1007/s00112-023-01782-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00112-023-01782-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Brown M, Brown A, et al. Energy conservation/envelope theory interventions. Fatigue: Biomedicine. Health &amp; Behavior. 2013;1:27&#x2013;42. doi: 10.1080/21641846.2012.733602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2012.733602</ArticleId><ArticleId IdType="pmc">PMC3596172</ArticleId><ArticleId IdType="pubmed">23504301</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudsmit EM, Nijs J, Jason LA, Wallman KE. Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: a consensus document. Disabil Rehabil. 2012;34:1140&#x2013;1147. doi: 10.3109/09638288.2011.635746.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09638288.2011.635746</ArticleId><ArticleId IdType="pubmed">22181560</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C, Bellmann-Strobl JT, Heindrich C et al (2023) Fighting post-COVID and ME/CFS &#x2013; development of curative therapies. Front Med 10.&#xa0;10.3389/fmed.2023.1194754</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10309204</ArticleId><ArticleId IdType="pubmed">37396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker N-P, Haberland A, Wenzel K, et al. A three-part, randomised study to investigate the safety, tolerability, pharmacokinetics and mode of action of BC 007, neutraliser of pathogenic autoantibodies against G-protein coupled receptors in healthy, young and elderly subjects. Clin Drug Investig. 2020;40:433&#x2013;447. doi: 10.1007/s40261-020-00903-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40261-020-00903-9</ArticleId><ArticleId IdType="pmc">PMC7181550</ArticleId><ArticleId IdType="pubmed">32222912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S, Catalogna M, Sasson E, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. 2022;12:11252. doi: 10.1038/s41598-022-15565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>U. S. National Library of Medidine ClinicalTrials.gov AT1001 for the treatment of long COVID. ClinicalTrials.gov Identifier: NCT05747534. https://classic.clinicaltrials.gov/ct2/show/NCT05747534. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>U. S. National Library of Medidine ClinicalTrials.gov The roles of vitamin D and microbiome in children with post-acute COVID-19 syndromes (PACS) and long COVID. ClinicalTrials.gov Identifier: NCT05633472. https://classic.clinicaltrials.gov/ct2/show/NCT05633472. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, et al. Long COVID symptoms and duration in SARS-CoV-2 positive children &#x2014; a nationwide cohort study. Eur J Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (ONS) (2023) Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023</Citation></Reference><Reference><Citation>Smith MS, Martin-Herz SP, Womack WM, Marsigan JL. Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine. Pediatrics. 2003;111:e376&#x2013;e381. doi: 10.1542/peds.111.4.e376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.111.4.e376</ArticleId><ArticleId IdType="pubmed">12671155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhof SL, Maijer K, Bleijenberg G, et al. Adolescent chronic fatigue syndrome: prevalence, incidence, and morbidity. Pediatrics. 2011;127:e1169&#x2013;e1175. doi: 10.1542/peds.2010-1147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-1147</ArticleId><ArticleId IdType="pubmed">21502228</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley EM, Emond AM, Sterne JAC. Unidentified chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics. BMJ Open. 2011;1:e000252&#x2013;e000252. doi: 10.1136/bmjopen-2011-000252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2011-000252</ArticleId><ArticleId IdType="pmc">PMC3244656</ArticleId><ArticleId IdType="pubmed">22155938</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley E, Sterne JAC. Association between school absence and physical function in paediatric chronic fatigue syndrome/myalgic encephalopathy. Arch Dis Child. 2009;94:752&#x2013;756. doi: 10.1136/adc.2008.143537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2008.143537</ArticleId><ArticleId IdType="pubmed">19001477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowsett EG, Colby J. Long-term sickness absence due to ME/CFS in UK schools. Journal of Chronic Fatigue Syndrome. 1997;3:29&#x2013;42. doi: 10.1300/J092v03n02_04.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v03n02_04</ArticleId></ArticleIdList></Reference><Reference><Citation>El Khoury J, Skoury M, El Khoury MY. The impact of post-COVID-19 syndrome in adolescents: a pilot study. Cureus. 2023 doi: 10.7759/cureus.40655.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.40655</ArticleId><ArticleId IdType="pmc">PMC10356177</ArticleId><ArticleId IdType="pubmed">37476124</ArticleId></ArticleIdList></Reference><Reference><Citation>European Commission (EU) (2022) Education and Training Monitor. Country Reports. https://op.europa.eu/webpub/eac/education-and-training-monitor-2022/en/country-reports/country-reports.html</Citation></Reference><Reference><Citation>Froehlich L, Hattesohl DBR, Jason LA, et al. Medical care situation of people with myalgic encephalomyelitis/chronic fatigue syndrome in Germany. Medicina. 2021;57:646. doi: 10.3390/medicina57070646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57070646</ArticleId><ArticleId IdType="pmc">PMC8306083</ArticleId><ArticleId IdType="pubmed">34201825</ArticleId></ArticleIdList></Reference><Reference><Citation>Froehlich L, Hattesohl DB, Cotler J, et al. Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome. J Health Psychol. 2022;27:2291&#x2013;2304. doi: 10.1177/13591053211027631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13591053211027631</ArticleId><ArticleId IdType="pmc">PMC9434257</ArticleId><ArticleId IdType="pubmed">34240650</ArticleId></ArticleIdList></Reference><Reference><Citation>Huckleberry Films Message in a bottle - long Covid SOS. https://www.youtube.com/watch?v=IIeOoS_A4c8.&#xa0;Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>The BMJ Opinion (2020) Counting long covid in children. Accessed 11/11/23 via: https://blogs.bmj.com/bmj/2020/10/16/counting-long-covid-in-children/</Citation></Reference><Reference><Citation>Au L, Capotescu C, Eyal G, Finestone G. Long covid and medical gaslighting: dismissal, delayed diagnosis, and deferred treatment. SSM - Qualitative Research in Health. 2022;2:100167. doi: 10.1016/j.ssmqr.2022.100167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ssmqr.2022.100167</ArticleId><ArticleId IdType="pmc">PMC9448633</ArticleId><ArticleId IdType="pubmed">36092770</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerson WU, Hoyle RH (2023) Pre-pandemic activity on a myalgic encephalomyelitis/chronic fatigue syndrome support forum is highly associated with later activity on a long COVID support forum for a variety of reasons: a mixed methods study. PLoS One Sep 8;18(9):e0291173. 10.1371/journal.pone.0291173</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10490974</ArticleId><ArticleId IdType="pubmed">37682908</ArticleId></ArticleIdList></Reference><Reference><Citation>LONG COViD KiDS We believe all children should be able to thrive and look forward to a positive future. https://www.longcovidkids.org/contact-9.&#xa0;Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>Elterninitiative ME/CSF-kranke Kinder &amp; Jugendliche M&#xfc;nchen e. V. (2023) Was ist ME/CFS?, ME/CFS und was jetzt? https://www.mecfs-kinder-muc.de/. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>NICHT GENESEN KIDS (2023) Wir suchen alle Eltern betroffener Kinder &amp; Jugendlicher deutschlandweit mit Post Covid, Post Vac, ME/CFS. https://nichtgenesenkids.org/.&#xa0;Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>Kokorelis C, Malone L, Byrne K, et al. Onset of postural orthostatic tachycardia syndrome (POTS) following COVID-19 infection: a pediatric case report. Clin Pediatr. 2023;62:92&#x2013;95. doi: 10.1177/00099228221113609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00099228221113609</ArticleId><ArticleId IdType="pmc">PMC9833997</ArticleId><ArticleId IdType="pubmed">35883258</ArticleId></ArticleIdList></Reference><Reference><Citation>Petracek LS, Broussard CA, Swope RL, Rowe PC. A case study of successful application of the principles of ME/CFS care to an individual with long COVID. Healthcare. 2023;11:865. doi: 10.3390/healthcare11060865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11060865</ArticleId><ArticleId IdType="pmc">PMC10048325</ArticleId><ArticleId IdType="pubmed">36981522</ArticleId></ArticleIdList></Reference><Reference><Citation>Petracek LS, Suskauer SJ, Vickers RF et al (2021) Adolescent and young adult ME/CFS after confirmed or probable COVID-19. Front Med 8. 10.3389/fmed.2021.668944</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116546</ArticleId><ArticleId IdType="pubmed">33996867</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C (Linda) MC, Rowe PC, Verheugt FWA, Visser FC (2021) Numeric rating scales show prolonged post-exertional symptoms after orthostatic testing of adults with myalgic encephalomyelitis/chronic fatigue syndrome. Front Med 7.&#xa0;10.3389/fmed.2020.602894</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874746</ArticleId><ArticleId IdType="pubmed">33585505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocon AJ, Messer ZR, Medow MS, Stewart JM. Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome. Clin Sci. 2012;122:227&#x2013;238. doi: 10.1042/CS20110241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20110241</ArticleId><ArticleId IdType="pmc">PMC3368269</ArticleId><ArticleId IdType="pubmed">21919887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bou-Holaigah I (1995) The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 274:961. 10.1001/jama.1995.03530120053041</Citation><ArticleIdList><ArticleId IdType="pubmed">7674527</ArticleId></ArticleIdList></Reference><Reference><Citation>Eder J, Schumm L, Armann JP, et al. Increased red blood cell deformation in children and adolescents after SARS-CoV-2 infection. Sci Rep. 2023;13:9823. doi: 10.1038/s41598-023-35692-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-35692-6</ArticleId><ArticleId IdType="pmc">PMC10276822</ArticleId><ArticleId IdType="pubmed">37330522</ArticleId></ArticleIdList></Reference><Reference><Citation>U. S. National Library of Medidine ClinicalTrials.gov Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (ME/CFS) Registry and Biobank, COVID-19, SARS-CoV-2 (MECFS-R). ClinicalTrials.gov Identifier: NCT05778006. https://classic.clinicaltrials.gov/ct2/show/NCT05778006?term=NCT05778006&amp;draw=2&amp;rank=1. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>U. S. National Library of Medidine ClinicalTrials.gov Munich Long COVID Registry Study for Children, Adolescents and Adults (MLC-R) (MLC-R). ClinicalTrials.gov Identifier: NCT05638724. https://classic.clinicaltrials.gov/ct2/show/NCT05638724?term=NCT05638724&amp;draw=2&amp;rank=1.&#xa0;Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>F&#xf6;rderinitiative f&#xfc;r die Versorgungsforschung zum Post-COVID-Syndrom Teilprojekt 2. Post-COVID Kids Bavaria &#x2013; PCFC (Post-COVID Fatigue Center). https://www.lgl.bayern.de/downloads/gesundheit/infektionsschutz/doc/post_covid_kids_bavaria_teilprojekt_2.pdf. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>Charit&#xe9; Fatigue Centrum Das Fatigue Centrum der Charit&#xe9; &#x2014; Universit&#xe4;tsmedizin Berlin. https://cfc.charite.de/forschung/immme/team/. Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>NINDS Common Data Elements Myalgic encephalomyelitis/chronic fatigue syndrome. https://www.commondataelements.ninds.nih.gov/MyalgicEncephalomyelitis/ChronicFatigueSyndrome.&#xa0;Accessed 11 Nov 2023</Citation></Reference><Reference><Citation>Munblit D, Nicholson T, Akrami A, et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir Med. 2022;10:715&#x2013;724. doi: 10.1016/S2213-2600(22)00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Buonsenso D, Sigfrid L, et al. Post-COVID-19 condition in children: a COS is urgently needed. Lancet Respir Med. 2022;10:628&#x2013;629. doi: 10.1016/S2213-2600(22)00211-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00211-9</ArticleId><ArticleId IdType="pmc">PMC9197248</ArticleId><ArticleId IdType="pubmed">35714657</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>